Promising Experimental ALS Drug
According to a recent study published in the New England Journal of Medicine an experimental drug for ALS/Lou Gehrig’s disease has slowed the neurological decline, offering hope to a population that is in need of new treatment options. Patients who received the drug in the closely monitored clinical trial are reported to have retained a …